Skip to main content

Xpogen Licenses PathlinX Software to Johns Hopkins

NEW YORK, May 8 - Bioinformatics company Xpogen today said it has licensed its PathlinX 3.0 gene expression-analysis software to Johns Hopkins Medical Center.

According to Cambridge, Mass.-based Xpogen, the PathlinX software was designed to identify differentially co-expressed genes in two-state method-of-action experiments.

 

"By creating visual networks of clinical and gene-expression data and integrating these results with more conventional techniques, we will be able to mine the genes that are key to a better understanding of the molecular mechanisms of pulmonary disease," said Joe Garcia, director of pulmonary and critical care Medicine at Johns Hopkins.

The Scan

UK Funds to Stay Ahead of Variants

The UK has announced a further £29.3 million to stay on top of SARS-CoV-2 variants, the Guardian reports.

Push for Access

In a letter, researchers in India seek easier access to COVID-19 data, Science reports.

Not as Cold

Late-stage trial results are expected soon for an RNA-based vaccine that could help meet global demand as it does not require very cold storage, the New York Times writes.

Genome Research Papers on Microbes' Effects on Host Transfer RNA, Honeybee Evolution, Single-Cell Histones

In Genome Research this week: influence of microbes on transfer RNA patterns, evolutionary relationships of honeybees, and more.